These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 4319134

  • 21. [New and future drugs in pulmonary tuberculosis].
    Grosset JH, Truffot-Pernot C, Lecoeur H.
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565
    [No Abstract] [Full Text] [Related]

  • 22. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S.
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract] [Full Text] [Related]

  • 23. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
    Malinowska B, Pawlak F.
    Gruzlica; 1970 Jul; 38(6):531-5. PubMed ID: 4317029
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
    Ibarra JP, Piñeyro J, Trenchi A, Tarallo NH, Lanne de Farriols ME, Cuñarro de Gimeno G, Fernández Latorre I.
    Hoja Tisiol; 1967 Jul; 24(1):5-88. PubMed ID: 4308762
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E.
    Wien Med Wochenschr; 1966 Nov 19; 116(47):996-8. PubMed ID: 6011782
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR.
    Bull Int Union Tuberc; 1968 Dec 19; 41():175-7. PubMed ID: 4885379
    [No Abstract] [Full Text] [Related]

  • 34. Clinical experience with ethambutol.
    Wilson TM.
    Antibiot Chemother; 1970 Dec 19; 16():222-9. PubMed ID: 4108890
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS.
    Vrach Delo; 1981 Jan 19; (1):47-9. PubMed ID: 7010782
    [No Abstract] [Full Text] [Related]

  • 37. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
    Tsukamura M.
    Iryo; 1966 Mar 19; 20(3):241-50. PubMed ID: 5964831
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The use of second line drugs in patients with drug resistance to standard tuberculostatics.
    Zierski M.
    Dis Chest; 1968 Apr 19; 53(4):421-6. PubMed ID: 5652478
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.